1. Home
  2. CRUS vs IMVT Comparison

CRUS vs IMVT Comparison

Compare CRUS & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cirrus Logic Inc.

CRUS

Cirrus Logic Inc.

N/A

Current Price

$117.52

Market Cap

6.0B

Sector

Technology

ML Signal

N/A

Logo Immunovant Inc.

IMVT

Immunovant Inc.

N/A

Current Price

$34.23

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRUS
IMVT
Founded
1984
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.3B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
CRUS
IMVT
Price
$117.52
$34.23
Analyst Decision
Buy
Buy
Analyst Count
5
17
Target Price
★ $136.67
$48.63
AVG Volume (30 Days)
701.2K
★ 1.3M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 30.83
N/A
EPS
★ 3.69
N/A
Revenue
★ $1,997,379,000.00
N/A
Revenue This Year
$0.89
N/A
Revenue Next Year
$4.08
N/A
P/E Ratio
$31.44
★ N/A
Revenue Growth
★ 5.34
N/A
52 Week Low
$105.10
$21.86
52 Week High
$180.42
$45.42

Technical Indicators

Market Signals
Indicator
CRUS
IMVT
Relative Strength Index (RSI) 51.90 55.13
Support Level $106.27 $26.01
Resistance Level $123.88 $35.44
Average True Range (ATR) 4.33 1.59
MACD 0.34 0.46
Stochastic Oscillator 52.36 56.39

Price Performance

Historical Comparison
CRUS
IMVT

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a supplier of low-power, low-latency, high-precision audio components that are used in a variety of applications, including smartphones, PCs, tablets, AR/VR headsets, wearables, home theater systems, automotive entertainment systems, and professional audio systems. The firm's products are organized into two streams: audio products and HPMS Products. These products include amplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters, and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, India, South Korea, and countries across the world.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: